Skip to main content

Tranexamic acid use is associated with reduced intraoperative blood loss during spine surgery for Marfan syndrome

Abstract

Purpose

The utility of tranexamic acid (TXA) in patients with Marfan syndrome (MFS) is uncertain given associated aberrations within the vasculature and clotting cascade. Therefore, this study aimed to assess the association of TXA use with intraoperative blood loss and allogeneic blood transfusions in patients with MFS who underwent spinal arthrodesis.

Methods

We queried our institutional database for MFS patients who underwent spinal arthrodesis for scoliosis between 2000 and 2020 by one surgeon. We excluded procedures spanning < 4 vertebral levels, those using anterior or combined anterior/posterior approaches, and those involving growing rods, postoperative infection, or spondylolisthesis. Fifty-two patients met our criteria, of whom 22 were treated with TXA and 30 were not. Mean differences in blood loss, transfusion volume, and proportions receiving transfusion were compared between TXA and the control groups using Student t, chi-squared, or Fisher exact tests. Alpha = 0.05.

Results

MFS patients treated with TXA experienced less mean (± standard deviation) intraoperative blood loss (1023 ± 534 mL) compared to the control group (1436 ± 1022 mL) (p = 0.01). The TXA group had estimated blood volume loss of 27% ± 16% compared to 36% ± 21% for controls (p = 0.05). No differences were found in allogeneic transfusion rate (p = 0.66) or transfusion volume (p = 0.15).

Conclusions

We found an association between TXA use and reduced blood loss during surgical treatment of MFS-associated scoliosis, suggesting that the connective tissue deficiency in MFS does not interfere with TXA’s mechanism of action.

Level of evidence

III.

This is a preview of subscription content, access via your institution.

Data availability

Not applicable.

Code availability

Not applicable.

References

  1. 1.

    Dietz HC, Cutting GR, Pyeritz RE et al (1991) Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352:337–339

    CAS  Article  Google Scholar 

  2. 2.

    Pyeritz RE, Francke U (1993) The second international symposium on the Marfan syndrome. Am J Med Genet 47:127–135

    CAS  Article  Google Scholar 

  3. 3.

    Sponseller PD, Bhimani M, Solacoff D et al (2000) Results of brace treatment of scoliosis in Marfan syndrome. Spine (Phila Pa 1976) 25:2350–2354

    CAS  Article  Google Scholar 

  4. 4.

    Sponseller PD, Hobbs W, Riley LH III et al (1995) The thoracolumbar spine in Marfan syndrome. J Bone Joint Surg Am 77:867–876

    CAS  Article  Google Scholar 

  5. 5.

    Bick RL (1979) Vascular disorders associated with thrombohemorrhagic phenomena. Semin Thromb Hemost 5:167–183

    CAS  Article  Google Scholar 

  6. 6.

    Bridges AB, Gray JR, McLaren M et al (1993) Endothelial cell and platelet function in Marfan’s syndrome. Endothelium 1:203–206

    Article  Google Scholar 

  7. 7.

    Erdohazi M, Cowie V, Lo SS (1964) A case of haemophilia with Marfan’s syndrome. Br Med J 1:102–103

    CAS  Article  Google Scholar 

  8. 8.

    Humphries JE, Stouffer GA, Kelly TE et al (1991) Hypercoagulability in a patient with Marfan syndrome. J Med Genet 28:349–351

    CAS  Article  Google Scholar 

  9. 9.

    Kornhuber KTI, Seidel H, Pujol C et al (2019) Hemostatic abnormalities in adult patients with Marfan syndrome. Cardiovasc Diagn Ther 9:S209–S220

    Article  Google Scholar 

  10. 10.

    Moran MM, Kroon D, Tredwell SJ et al (1995) The role of autologous blood transfusion in adolescents undergoing spinal surgery. Spine (Phila Pa 1976) 20:532–536

    CAS  Article  Google Scholar 

  11. 11.

    Liang W, Yu B, Wang Y et al (2015) Comparison of posterior correction results between Marfan syndrome scoliosis and adolescent idiopathic scoliosis-a retrospective case-series study. J Orthop Surg Res 10:73

    Article  Google Scholar 

  12. 12.

    Lipton GE, Guille JT, Kumar SJ (2002) Surgical treatment of scoliosis in Marfan syndrome: guidelines for a successful outcome. J Pediatr Orthop 22:302–307

    PubMed  Google Scholar 

  13. 13.

    Palmisani M, Dema E, Rava A et al (2019) Surgical treatment of spinal deformities in Marfan syndrome: Long-term follow-up results using different instrumentations. J Craniovertebr Junction Spine 10:172–178

    Article  Google Scholar 

  14. 14.

    Di Silvestre M, Greggi T, Giacomini S et al (2005) Surgical treatment for scoliosis in Marfan syndrome. Spine (Phila Pa) 30:E597–E604

    Article  Google Scholar 

  15. 15.

    Kurucan E, Bernstein DN, Ying M et al (2019) Trends in spinal deformity surgery in Marfan syndrome. Spine J 19:1934–1940

    Article  Google Scholar 

  16. 16.

    Zenner J, Hitzl W, Meier O et al (2014) Surgical outcomes of scoliosis surgery in Marfan syndrome. J Spinal Disord Tech 27:48–58

    Article  Google Scholar 

  17. 17.

    Hunt BJ (2015) The current place of tranexamic acid in the management of bleeding. Anaesthesia 70(Suppl 1):50–3,e18

    CAS  Article  Google Scholar 

  18. 18.

    Chauncey JM, Wieters JS (2021) Tranexamic Acid.

  19. 19.

    Anand A, Melvin JS (2016) Tranexamic acid in hip and knee arthroplasty. J Am Acad Orthop Surg 24:e59

    Article  Google Scholar 

  20. 20.

    Lin ZX, Woolf SK (2016) Safety, Efficacy, and Cost-effectiveness of Tranexamic Acid in Orthopedic Surgery. Orthopedics 39:119–130

    Article  Google Scholar 

  21. 21.

    Slattery C, Kark J, Wagner T et al (2019) The use of tranexamic acid to reduce surgical blood loss: a review basic science, subspecialty studies, and the evolution of use in Spine deformity surgery. Clin Spine Surg 32:46–50

    Article  Google Scholar 

  22. 22.

    Yoo JS, Ahn J, Karmarkar SS et al (2019) The use of tranexamic acid in spine surgery. Ann Transl Med 7:S172

    CAS  Article  Google Scholar 

  23. 23.

    Qiao J, Xu L, Liu Z et al (2016) Surgical treatment of scoliosis in Marfan syndrome: outcomes and complications. Eur Spine J 25:3288–3293

    Article  Google Scholar 

  24. 24.

    Shirley ED, Sponseller PD (2009) Marfan syndrome. J Am Acad Orthop Surg 17:572–581

    Article  Google Scholar 

  25. 25.

    Jones KB, Erkula G, Sponseller PD et al (2002) Spine deformity correction in Marfan syndrome. Spine (Phila Pa 1976) 27:2003–2012

    Article  Google Scholar 

  26. 26.

    Chung AS, Renfree S, Lockwood DB et al (2019) Syndromic scoliosis: national trends in surgical management and inpatient hospital outcomes: a 12-year analysis. Spine (Phila Pa 1976) 44:1564–1570

    Article  Google Scholar 

  27. 27.

    Li ZC, Liu ZD, Dai LY (2011) Surgical treatment of scoliosis associated with Marfan syndrome by using posterior-only instrumentation. J Pediatr Orthop B 20:63–66

    Article  Google Scholar 

  28. 28.

    von Kodolitsch Y, Demolder A, Girdauskas E et al (2019) Features of Marfan syndrome not listed in the Ghent nosology - the dark side of the disease. Expert Rev Cardiovasc Ther 17:883–915

    Article  Google Scholar 

  29. 29.

    Nadler SB, Hidalgo JH, Bloch T (1962) Prediction of blood volume in normal human adults. Surgery 51:224–232

    PubMed  Google Scholar 

Download references

Acknowledgements

For their editorial assistance, we thank Jenni Weems, MS, Kerry Kennedy, BA, and Rachel Box, MS, in the Editorial Services group of The Johns Hopkins Department of Orthopaedic Surgery.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Author information

Affiliations

Authors

Contributions

II: Substantial contributions to conception and design; acquisition of data; analysis; interpretation of data; drafting the article; final approval of the version to be published. AM: Revising it critically for important intellectual content; final approval of the version to be published. PDS: Substantial contributions to conception and design; interpretation of data; revising it critically for important intellectual content; final approval of the version to be published.

Corresponding author

Correspondence to Paul D. Sponseller.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to report.

Ethics approval

This study was approved by the Johns Hopkins Medicine Institutional Review Boards.

Consent to participate

Formal consent was not required for this type of study.

Consent for publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ikwuezunma, I.A., Margalit, A. & Sponseller, P.D. Tranexamic acid use is associated with reduced intraoperative blood loss during spine surgery for Marfan syndrome. Spine Deform (2021). https://doi.org/10.1007/s43390-021-00416-1

Download citation

Keywords

  • Connective tissue deficiency
  • Intraoperative blood loss
  • Marfan syndrome
  • Posterior spinal arthrodesis
  • Risk modification
  • Syndromic scoliosis
  • Tranexamic acid